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Duration of Fluoroscopic-Guided Spine Interventions
and Radiation Exposure Is Increased in Overweight
Patients
Matthew Smuck, MD, Patricia Zheng, BS, Timothy Chong, MD,
Ming-Chih Kao, MD, PhD, Michael E. Geisser, PhDBackground: The impact of patient body mass index (BMI) on image-guided spine
interventions remains unknown. Higher BMI is known to complicate the acquisition of
radiographic images. Therefore it can be hypothesized that the patient’s body habitus can
influence the delivery of a spinal injection.
Objective: To quantify the impact of patient BMI on the length of fluoroscopy and
procedure times during spine interventions.
Design: Secondary analysis of 2 prospective observational studies.
Setting: All injections were performed in an outpatient university setting.
articipants: A total of 209 patients in whom spine injections were performed (99
women), with a mean age of 54.6 years.
Methods: The fluoroscopy times for 202 participants and total procedure times for 137
participants were recorded. Additional participant characteristics, including age, gender,
BMI, and actual procedures performed, also were collected. Analysis of covariance and
linear and nonlinear model analysis were performed to assess the effect of BMI on fluoros-
copy and procedure times.
Main Outcome Measurements: Fluoroscopy time and procedure duration times.
Results: Participants had a mean age of 54.6 years, 51% were men, and 77% (n 155) were
overweight (BMI 25). Participants received the following interventions: 40 zygapophyseal
joint injections, 33 medial branch nerve blocks, 113 transforaminal epidural injections, and 16
combined zygapophyseal joint injections and epidural injections. Gender, procedure number,
and procedure type did not differ between groups. The overweight group demonstrated a 30%
increase in mean fluoroscopy time and a 35% increase in mean procedure time. Controlling for
other variables, we found that differences in fluoroscopy time and procedure time were
significant (P .032 and P .031, respectively) between the 2 groups.
Conclusions: Significantly prolonged procedure time and fluoroscopy time in over-
weight patients increase the risks associated with spine interventions, not only to the
patients but also to the operating room staff exposed to ionizing radiation.
PM R 2013;5:291-296
INTRODUCTION
Low back pain (LBP) plagues industrialized societies. Some researchers suggest that the inci-
dence of LBP is increasing in part because of the growing obesity epidemic [1,2]. Although an
association between obesity and LBP has not been found in all studies [2,3], in 2 independent
studies, authors found that a body mass index (BMI) greater than 30 is associated with a 1.7-fold
increased odds of developing back pain with disability [4,5]. Kaila-Kangas et al [6] found that a
BMI within the overweight range (BMI27.5 kg/m2) was associated with a 2.7-fold increase in
he odds of back pain. Furthermore, weight reduction achieved via surgical means has been
eported to significantly reduce or even resolve chronic LBP [7].
Recently published practice guidelines from the American College of Physicians and the
merican Pain Society recommend consideration of spine injections for treatment of certain
umbar spine conditions when patients do not respond to standard noninvasive therapies [8].
hese interventions generally are performed under fluoroscopic guidance to improve their
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292 Smuck et al FLUOROSCOPY AND RADIATION IN OVERWEIGHT PATIENTSaccuracy and safety. Higher BMI is known to compromise the
acquisition of medical images, reduce image quality, and neces-
sitate greater doses of radiation to obtain images of deep struc-
tures [9,10]. In addition, it complicates positioning and in-
creases rates of postsurgical complications in spine surgery
[11,12]. This study was initiated to investigate the impact of
being overweight on percutaneous spine interventions. To our
knowledge, this is a previously unexplored topic.
METHODS
This investigation was a secondary analysis of data obtained
from 2 prospective observational studies, one in which the
authors studied lumbar transforaminal epidural injections
alone and another in which the authors studied multisite
lumbar injections, including medial branch blocks, bilateral
or multilevel zygapophyseal joint injections, or a combina-
tion of lumbar transforaminal epidural injections and zyg-
apophyseal joint injections [13,14]. This analysis was ap-
roved by the University of Michigan institutional review
oard and was compliant with the Health Insurance Porta-
ility and Accountability Act.
During the data collection time frame between March 2006
nd September 2008, all patients scheduled by their treating
pine surgeon or physiatrist for a percutaneous spine interven-
ion were considered as candidates for the index studies. Exclu-
ion criteria were allergy to contrast, pregnancy, coagulopathy,
ystemic infection, mental disability, and inability to give in-
ormed consent. From the original study cohorts, all partici-
ants who received lumbar medial branch nerve blocks, lumbar
ygapophyseal joint injections, and/or lumbosacral transforam-
nal epidural injections were included in the current study. All
njections were performed by one experienced fellowship-
rained interventionalist (M.S.) and several fellows under his
irect supervision in an outpatient university setting.
The patient data collected included age, gender, BMI
defined as weight in kilograms divided by height in meters
quared), procedure level(s) and side(s), fluoroscopy time,
nd procedure time. For single injections, fluoroscopy time
in seconds) was automatically measured by the fluoroscope
GE OEC 9800, Salt Lake City, UT) and defined as the total
uoroscopy time recorded. Procedure time was measured
ith use of a stopwatch by a research assistant in the proce-
ure room. The assistant started the stopwatch when the
eedle attached to the syringe containing local anesthetic first
enetrated the patient’s skin and stopped it when the treat-
ent needle was removed from the patient.
In cases in which more than one level or side was injected,
he time of the administration of fluoroscopy and of the proce-
ure were recorded for the entire combination of injections and
hen converted to a per-injection format. Specifically, the total
uration of fluoroscopy and the procedure was measured con-
inuously from the first injection to the last injection. Then, to
ormalize the data on a per-injection basis, the total durations ofthe fluoroscopy and procedure were divided by the number of
injections performed for that participant.
Values used to define normal weight and overweight were
determined by the World Health Organization BMI criteria:
normal is 18.50-24.99, and overweight is 25.00 (World
Health Organization, 2004, http://www.who.int/mediacentre/
factsheets/fs311/en/). To detect any pre-existing association be-
tween weight and age, gender, and type of procedure,2 tests were
erformed to evaluate weight in terms of those characteristics.
To examine the distributional characteristics of fluoroscopy
nd procedure duration, we calculated the means, SDs, skew-
ess, and kurtosis. The normality of each distribution was tested
ith the use of a one-sample Kolmogorow-Smirnov Goodness-
f-Fit test. Data with significant Z values were normalized by log
ransformation. To account for the potential confounding effects
f age, analysis of covariance was performed on the log-trans-
ormed fluoroscopy and procedure times, with weight group
normal versus overweight) and age as the covariates. Additional
nalyses that used generalized additive model were performed
o account for the number of procedures, age, and gender and to
ssess nonlinearity of BMI’s effect. All analyses were performed
ith the statistical analysis software (SAS) 8.2 software package
SAS Institute, Inc., Cary, NC), R (http://r-project.org), and STATA
Statistics/Data Analysis 12.0 (StataCorp LP, College Station, TX).
RESULTS
In this study, we examined spine injections performed on
202 patients, 99 of whom were women, with a mean age of
54.6 years (SD 15.4). All participants were divided into
normal-weight and overweight groups, with 47 (23.3%) and
155 (76.7%) in each group, respectively.
The distribution of interventions included 40 patients
with zygapophyseal joint injections, 33 with medial branch
nerve blocks, 113 with transforaminal epidural injections,
and 16 with combined zygapophyseal joint injections and
transforaminal epidural injections (Table 1). Because proce-
dure times can vary on the basis of the number and type of
injections, these factors were extensively analyzed. Most im-
portantly, no statistical differences were found in the propor-
tions of injection types or the average number of injections
per patient in the 2 groups. Furthermore, no observable
trends were noted between weight class and gender or types
of procedure performed in our sample populations.
Overweight patients were younger than patients of normal
weight (t 1.84, P .068), although this difference did not
reach statistical significance. Regardless, age was examined as
a covariate in the subsequent statistical tests in which we
compared normal versus overweight subjects in terms of
fluoroscopy and procedure times.
Average fluoroscopy time per procedure was 10.1 seconds
(SD6.1) in the normal-weight group and 13.1 seconds (SD
12.4) in the overweight group. Plotting the measured fluoros-
copy time by weight class revealed a skewed distribution, with
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293PM&R Vol. 5, Iss. 4, 2013the vast majority of fluoroscopy times falling in the 5-25 second
range, and outlying fluoroscopy times, prolonged up to 110
seconds, exclusively found in overweight patients (Figure 1).
Table 1. Subject characteristics
Variable
Normal
Weight
(n  47)
Overweight
(n  155)
P
Value
Total
(n  202)
ge, y (SD) 58.2 (17.5) 53.5 (14.6) .068 54.6 (15.4)
ender, n (%)
Male 22 (46.8) 81 (52.3) .618 47 (51.0)
Female 25 74 99
ace
White 17 56 .749* 73
Nonwhite 4 11 15
Unknown 26 88 .868† 114
rocedure side‡
Left 41 111 .234 152
Right 34 129 163
rocedure type
z-joint only 10 30 .835 40
z-joint and
epidural
1 15 .125 16
Medial branch
Nerve blocks
10 23 .999 33
Epidural only 26 87 .999 113
Procedure level
L1/L2 4 9 .314 13
L2/L3 13 32 .350 45
L4/L5 29 102 .796 131
L5/S1 33 118 .615 151
S1/S2 5 15 .586 20
Total 84 276 360
*Compared with nonwhite known race.
†Compared with known race (either white or nonwhite).
‡Some individuals received both right and left procedures.
Figure 1. Stacked bar chart showing increased fluoroscopic t
BMI  body mass index.Because the length of the procedure was not recorded on
the earliest-included participants in the index study, proce-
dure time only was available for the final 137 of the 202
subjects. Following a trend similar to the fluoroscopy time,
average procedure time was 88.5 seconds (SD 52.4) in the
normal-weight group and 119.5 seconds (SD 92.2) in the
overweight group. Time of procedure also was associated
with a similarly skewed distribution, with the majority of
procedure times in the 90-240 second range and outlying
procedure times prolonged up to 585 seconds found exclu-
sively in overweight patients (Figure 2). Overall, the fluoros-
copy time in patients with a BMI25 was increased by 30%
and the procedure time was increased by 35%. Because both
the time of the fluoroscopy and procedure were found to be
positively skewed (skewness 4.6 and 2.6, respectively), the
normality of each distribution was tested with a one-sample
Kolmogorow-Smirnov Goodness-of-Fit test. For both the
time of fluoroscopy and the procedure, the resulting Z value
was statistically significant, indicating that the observed dis-
tributions significantly deviated from a standard normal dis-
tribution (Z  2.65, P  .001; and Z  2.31, P  .001,
respectively). In an attempt to normalize the distributions,
individual fluoroscopy and procedure times were log-trans-
formed. When testing the log-transformed data, we found
that the Z values were no longer significant, indicating that
the transformations were successful in normalizing the dis-
tributions. The mean and SD of the fluoroscopy and proce-
dure times for the raw and log-transformed data are pre-
sented in Table 2. Analysis of covariance conducted on the
log-transformed fluoroscopy data indicated that there was a
significant main effect of weight class when we controlled for
age [F(1,134)  4.76, P  .031]. A similar analysis con-
ducted on log-transformed procedure times revealed a signif-
overweight patients compared with normal-weight patients.imes in
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294 Smuck et al FLUOROSCOPY AND RADIATION IN OVERWEIGHT PATIENTSicant main effect of weight class when we controlled for age
[F(1,199) 4.66, P .032]. A generalized additive model in
which we controlled for age, the number, and type of injec-
tions revealed that BMI is a linear predictor of fluoroscopy
time in log scale.
DISCUSSION
Several authors have shown that obese patients are more likely
to experience LBP [3-5]. Because the rate of obesity is antici-
ated to increase, the rate of LBP also may increase. Despite the
ncreasing use of image-guided spine interventions for the treat-
ent of LBP and the increasing rates of obesity, the impact of
reater BMI on these procedures has remained unknown.
Spine injections without fluoroscopic guidance often are
naccurate. Needles are misplaced in 25%-36% of caudal epidu-
al injections and in 7%-30% of lumbar interlaminar epidural
njections without fluoroscopic guidance [15,16]. Studies have
hown an even lower chance of correct needle placement with-
ut x-ray screening in obese patients [17]. Thus the use of
uoroscopy and iodinated contrast has become the standard of
Figure 2. Stacked bar chart showing increased procedure time
body mass index.
Table 2. Means and SDs (in parentheses) for the raw and
log-transformed fluoroscopy and procedure time for normal
and overweight groups
Variable
Normal–Weight
Patients
Overweight
Patients ANCOVA
Fluoroscopy time, s 10.1 (6.1) 13.1 (12.4)
Log fluoroscopy
time, s
2.14 (0.60) 2.34 (0.65) P  .032
Procedure time, s 88.5 (52.4) 119.5 (92.2)
Log procedure
time, s
4.33 (0.54) 4.58 (0.60) P  .031iANCOVA  analysis of covariance.are, leading to improved outcomes and reduced complications
18,19]. However, fluoroscopic-guided needle placement in
verweight patients is complicated by difficulty in image acqui-
ition and reduced image quality [20]. Given these difficulties,
e hypothesized that overweight patients would necessitate
ncreased procedure time and increased exposure to radiation
uring their procedures.
Indeed, our analysis showed that overweight patients
ften necessitated longer fluoroscopy and procedure times
ompared with patients of normal weight. Outliers (with
uoroscopy times up to 110 seconds and procedure times up
o 585 seconds) were limited to the overweight patients. The
ncreased distance from skin to target may account for some
f the increased times measured in this study, but other
actors are just as likely involved. In our opinion, difficulties
n image acquisition and reduced image quality likely play a
arger role. It is also possible that overweight patients had
ore degenerative spine disease, causing further difficulty
ith needle placement. However, in this study the over-
eight group was younger than the normal-weight group
nd thus less likely to have greater degeneration. Further-
ore, the association between obesity and degenerative spine
isease is not as clear as its association to LBP. Research has
uggested that obesity may actually protect from common
orms of spine degeneration; a study of Finnish twin patients
howed that greater body mass actually was associated with
ess disk desiccation, contrary to current views [21,22].
Increased length of fluoroscopic time and procedure times are
ot benign findings. Prolonged procedure times are known to
ncrease complication rates in procedures such as cordocentesis
23], cerebral angiography [24], and knee replacements, requiring
he use of a tourniquet [25]. Increased time of fluoroscopy signifies
rweight patients compared with normal-weight patients. BMI s in ovencreased exposure to radiation. Risks from ionizing radiation are
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295PM&R Vol. 5, Iss. 4, 2013cumulative over a lifetime and increase with dose [26,27]. Risks
include increasedchanceofdevelopingcataracts, leukemia, thyroid
cancer,breastcancer, stomachcancer,coloncancer,ovariancancer,
and skin cancer [28-30].
The average yearly radiation exposure for an individual is
approximately 360 mrem/yr, with 15% attributed to medical
radiation exposure [26]. Schmid et al [31] found that 1-3
minutes of continuous fluoroscopy resulted in an effective
dose of 43-125 mrem to the patient. In obese patients the
radiation risk is even greater, because to maintain optimal
imaging quality, the automatic brightness controls of most
c-arm fluoroscopes automatically increase both the current
and voltage of the x-ray beam [32]. Overweight patients also
bsorb more radiation from a beam than do thinner patients
ecause of the increased length of beam penetration through
he body, greater radiation scatter, and subsequent increased
bsorption of the scattered radiation [33]. Therefore over-
weight patients are not only exposed to the increased time of
radiation exposure determined here but also receive a greater
amount of radiation per second of exposure, which com-
pounds the risk of added fluoroscopy time in these patients.
Increased time of fluoroscopy also poses hazards to the
physician and procedure room staff. Scatter radiation from
the patient dissipates at the inverse square of the distance
from the source, placing the physician in the room at the
greatest risk as the result of proximity. While assessing radi-
ation exposure to the spine surgeon during fluoroscopically
assisted thoracolumbar pedicle screw placement, Ramper-
saud et al [34] found that the mean dose rate to the neck was
8.3 mrem/min, the dose rate to the torso when the surgeon
was positioned ipsilateral to the beam source was 53.3 mrem/
min, and the average hand dose rate was 58.2 mrem/min.
The prolonged procedural time in overweight patients would
subject the interventionalist to additional radiation. In addi-
tion, the increased procedural time subjects the intervention-
alist to the extra rigors of wearing heavy lead aprons and
remaining in static postures for the prolonged time of the
procedure. Therefore it is important for interventionalists
and their staff to be aware of these risks and take care to
optimize all controllable variables during procedures.
Time of fluoroscopy was used as a surrogate for radiation
exposure but does not directly measure the effective dose. On
the basis of the radiation dose estimations provided by
Schmid et al [31], a small 10-second increase in fluoroscopy
time translates to a 7.2-mrem increase in radiation exposure
to the patient, or nearly 2% of the average individual’s annual
radiation dose. This study revealed an average 3-second
increase in the time of the fluoroscopy procedure for over-
weight patients, translating to a 2.1-mrem increase in radia-
tion exposure per patient. With adequate distance and
proper shielding, the estimated radiation dose to the operator
during fluoroscopic procedures is generally 0.1% of that to
the patient [35]. Thus a crude estimate of the impact on the
treating physician is possible. Hypothetically speaking, abusy interventionalist performing a single spine injection
during 1000 patient encounters per year, with the national
average of 2 of 3 patients overweight, can expect to be
exposed to a 1.4-mrem increase in radiation annually (1000
patients/yr  2/3 overweight patients  2.1 mrem average
increase dose per overweight patient 0.1% estimated phy-
sician dose  1.4 mrem/yr). Although this amount is a
fraction of the annual occupational dose limit, radiation risk
is cumulative over a lifetime. In addition, for reasons listed in
the aforementioned paragraphs, these calculations likely un-
derestimate the true radiation dose increases to the patient
and physician. A prospective study can be designed to pro-
vide more accurate estimates of obesity’s impact on radiation
dose during spine interventions.
This study has several limitations. First, the injections were
performed by a single physician. Injection styles and results may
differ with alternate providers. Second, the interventionalist was
not blinded to the weight of the patient. Third, procedure time
was not available for approximately the earliest third of the
recruited subjects. However, in this regard, the analysis pro-
vided statistically significant results, suggesting that a larger
sample size was not necessary. Because the data from this study
were collected for purposes of another investigation, we were not
able to control several other factors. For instance, we were not able
to evaluate the procedures to determine the potential sources of
increased fluoroscopy and procedure time in overweight patients.
Evaluatingprocedure timeforpatientswhoreceiveasingleuniform
type of injection would have been a simpler and purer approach to
the questions asked in this study. However, when we controlled for
multiple injections in our data analysis and evaluated the number
andtypeof injectionsreceivedbypatients in the2groups,wefound
nostatisticallysignificantdifferences.Furthermore,webelievethese
data more closely represent a real-world practice in which some
patients receive a single injection and some receive multiple injec-
tions. Thus we believe that these results are more representative of
and applicable to general practice.
CONCLUSION
Given the findings of our study, we recommend that the concept
of “as low as reasonably achievable” be rigorously implemented
while performing fluoroscopy-guided procedures on over-
weight patients. Similarly, the use of protective shielding should
be considered to reduce scattered radiation exposure [17,34].
inally, because overweight patients may be technically more
hallenging, as suggested by the increased time fluoroscopic and
rocedure times, care must be taken to manage these patients to
aximize safety for all parties involved.
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This CME activity is designated for 1.0 AMA PRACategory 1 Credit™ and
can be completed online at me.aapmr.org. Log on to www.me.aapmr.org,
go to Lifelong Learning (CME) and select Journal-based CME from the
drop down menu. This activity is FREE to AAPM&R members and $25 for
non-members.CME Question
What effect does Body Mass Index (BMI) have on fluoroscopically guided low back pain procedures?
a. Patients with a BMI greater than 25 undergoing a fluoroscopic procedure for back pain may be exposed to higher levels of ionizing
radiation and prolonged procedure times.
b. A BMI of greater than 20 increases the likelihood of undergoing a fluoroscopic procedure.
c. A BMI of less than 25 increases the risk of radiation exposure to the physician performing these procedures over time.
d. The BMI of a patient has no impact on radiation and procedure times for interventional treatment of low back pain.
Answer online at me.aapmr.org
